The market cap of T2 at this price is only 8 million. 11 million in revenue and future revenues will increase. This market for tests is in the billions? At the very least with Fda approvals in pipe line this should be trading at a multiple ×3. It was a 7 dollar a share company. Heck shell companies have a MC close to this. $1.20 gives us a Mc of 30 million very reasonable with no RS. Stock was sold down snd shorted way too low. I don't believe that fish hack write up about no money in testing for sepsis quick. He could be way wrong you know.
News 
Market Data 
Discover 
